B

Boditech Med Inc
KOSDAQ:206640

Watchlist Manager
Boditech Med Inc
KOSDAQ:206640
Watchlist
Price: 12 070 KRW -3.82%
Market Cap: ₩264.5B

Boditech Med Inc
Non-Reccuring Items

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Boditech Med Inc
Non-Reccuring Items Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Non-Reccuring Items CAGR 3Y CAGR 5Y CAGR 10Y
B
Boditech Med Inc
KOSDAQ:206640
Non-Reccuring Items
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
I
I Sens Inc
KOSDAQ:099190
Non-Reccuring Items
-₩7.3B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
C
Classys Inc
KOSDAQ:214150
Non-Reccuring Items
₩0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
W
Won Tech Co Ltd
KOSDAQ:336570
Non-Reccuring Items
-₩109.6m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
V
Viol Co Ltd
KOSDAQ:335890
Non-Reccuring Items
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
S
Seers Technology Co Ltd
KOSDAQ:458870
Non-Reccuring Items
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Boditech Med Inc
Glance View

Market Cap
264.5B KRW
Industry
Health Care

Boditech Med, Inc. engages in the provision of in-vitro diagnostics analyzers and reagents. The company is headquartered in Chuncheon, Gangwon-Do. The company went IPO on 2014-12-29. The firm is engaged in the manufacture and sale of antigen diagnostic kits and other products. In addition, the Company is engaged in the manufacture and sale of cancer diagnostic kit, drug concentration diagnostic kit and other products. The firm sells its products within domestic market and to overseas markets. The firm was established in 1998 and is located in Chuncheon-si, Gang-won-do, South Korea.

Intrinsic Value
26 419.7 KRW
Undervaluation 54%
Intrinsic Value
Price ₩12 070
B

See Also

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett